Spacer length and serum protein adsorption affect active targeting of trastuzumab-modified nanoparticles.

Barth C., Spreen H., Mulac D., Keuter L., Behrens M., Humpf H.-U., Langer K.

Research article (journal) | Peer reviewed

Details about the publication

JournalBiomaterials and Biosystems (Biomater Biosyst)
Volume5
Page range100032null
StatusPublished
Release year2022
Language in which the publication is writtenEnglish
DOI10.1016/j.bbiosy.2021.100032
KeywordsNanoparticles; Human serum albumin; Polyethylene glycol; Trastuzumab; Active targeting; Protein corona; Human serum; Proteomics

Authors from the University of Münster

Barth, Christina
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)
Behrens, Matthias
Institute of Food Chemistry
Humpf, Hans-Ulrich
Professur für Lebensmittelchemie (Prof. Humpf)
Keuter, Lucas
Professur für Lebensmittelchemie (Prof. Humpf)
Langer, Klaus
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)
Mulac, Dennis
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)
Spreen, Hendrik
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)